Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia

ClinicalTrials.gov ID: NCT00136760

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT00136760. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:49 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Incentives Plus Bupropion for Smoking in Schizophrenics

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

There is a high prevalence of smoking among people with schizophrenia, and there are few smoking treatment programs for these smokers. The aims of this study are to investigate the separate and combined effects of bupropion and a voucher incentive program on smoking in people with schizophrenia.

Study identification

NCT ID: NCT00136760
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Brown University; Other
Enrollment: 57 participants

Conditions and interventions

Conditions

Interventions

Bupropion Drug
Contingent reinforcement plus placebo Drug
non-contingent reinforcement plus bupropion Drug
Non-contingent reinforcement plus placebo Drug

Drug

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 2003 (Type not available)
Primary completion: Mar 2009 (Actual)
Completion: Mar 2009 (Actual)
Last update posted: Oct 7, 2015

2003 – 2009

United States locations

U.S. sites: 1
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Brown University	Providence	Rhode Island	02912	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT00136760, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 7, 2015 · Synced Nov 15, 2026